ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,459.10
1.11%
Dow Jones
40,589.34
1.64%
US Dollar vs MXN
18.4592
0.00%
Brent Oil
79.745
0.00%
Bitcoin
69,206.40
1.90%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NYSE
  6. Merck and Co Inc (MRK)

  7. Merck and Co Inc (MRK) Noticias

MRK Merck and Co Inc

125.26
-0.59 (-0.47%)
26 Jul 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Merck and Co Inc MRK NYSE Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.59 -0.47% 125.26 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
126.84 125.05 128.73 125.26 125.85
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
26/7/202405:50BWMerck Receives Positive EU CHMP Opinion for KEYTRUDA®..
23/7/202411:52BWMerck Announces Fourth-Quarter 2024 Dividend
23/7/202405:45BWMerck Announces Topline Results from Phase 2b/3 Trial of..
16/7/202405:45BWMerck to Share New Research and Host Community-Focused..
12/7/202405:45BWMerck Completes Acquisition of EyeBio
09/7/202407:30BWMerck Animal Health Completes Acquisition of Elanco’s Aqua..
09/7/202407:28PRNUSElanco Completes Sale of Aqua Business
01/7/202407:15BWMerck and Orion Announce Mutual Exercise of Option Providing..
01/7/202405:45BWMerck to Hold Second-Quarter 2024 Sales and Earnings..
28/6/202405:53BWMerck Receives Positive EU CHMP Opinion for WINREVAIR™..
27/6/202419:18BWCDC’S ACIP Unanimously Recommends Merck’s CAPVAXIVE™..
27/6/202406:13IHMARKETNEWSInteractive Brokers Loses $48 Million on NYSE, Amazon..
26/6/202418:45BWPatritumab Deruxtecan BLA Submission Receives Complete..
25/6/202415:05BWUSDA Approves Merck Animal Health’s NOBIVAC® NXT Canine Flu..
18/6/202406:02IHMARKETNEWSFisker Files for Bankruptcy, Chegg Stocks Rise on 23%..
17/6/202416:29BWU.S. FDA Approves CAPVAXIVE™ (Pneumococcal 21-valent..
17/6/202416:15BWFDA Approves Merck’s KEYTRUDA® (pembrolizumab) Plus..
05/6/202405:45BWMerck to Participate in the Goldman Sachs 45th Annual Global..
04/6/202414:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202414:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202413:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202413:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202413:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202413:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202413:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202413:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202413:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202413:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202413:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202408:10IHMARKETNEWSEconomic Worries May Lead To Weakness On Wall Street
30/5/202415:39EDGAR2Form CERT - Certification by an exchange approving..
30/5/202415:28EDGAR2Form 8-A12B - Registration of securities [Section 12(b)]
30/5/202415:14EDGAR2Form 8-K - Current report
29/5/202408:10IHMARKETNEWSRising Treasury Yields May Weigh On Wall Street
29/5/202406:34IHMARKETNEWSRobinhood Shares Surge 3.3% on Stock Buyback Announcement;..
29/5/202406:15BWFDA Grants Priority Review to Merck’s Application for..
29/5/202405:45BWMerck to Acquire EyeBio
28/5/202415:44IHMARKETNEWSNasdaq Climbs To Another Record Closing High But Dow Sees..
28/5/202415:31EDGAR2Form SD - Specialized disclosure report
28/5/202414:12BWMerck Announces Third-Quarter 2024 Dividend
28/5/202405:45BWMerck Announces Phase 3 KEYNOTE-522 Trial Met its Overall..
20/5/202405:28EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
16/5/202415:15EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
15/5/202410:31EDGAR2Form POSASR - Post-effective Amendment to an automatic shelf..
15/5/202405:45BWMerck to Present New Data at 2024 ASCO Annual Meeting..
13/5/202405:45BWMerck Provides Update on Phase 3 KeyVibe-010 Trial..
09/5/202406:05PRNCASanté Canada approuve KEYTRUDA® pour le traitement, en..
09/5/202405:45BWMerck Provides Update on Phase 3 KEYNOTE-B21 Trial..
08/5/202405:45BWMerck to Participate in the Bank of America Securities 2024..
06/5/202415:29EDGAR2Form 144 - Report of proposed sale of securities

Su Consulta Reciente

NYSE
MRK
Merck
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados